Kazia Therapeutics Ltd
ASX:KZA
Kazia Therapeutics Ltd
ASX:KZA
Price:
0.08 AUD
Market Closed
Updated:
May 20, 2024
Kazia Therapeutics Ltd
EPS (Diluted)
|
Kazia Therapeutics Ltd
EPS (Diluted) Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kazia Therapeutics Ltd
ASX:KZA
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
12%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-6%
|
|
|
Immutep Ltd
ASX:IMM
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Mesoblast Ltd
ASX:MSB
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
EPS (Diluted)
$5
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kazia Therapeutics Ltd's EPS (Diluted)?
EPS (Diluted)
-0.1
AUD
-0.1
AUD
Based on the financial report for Jun 30, 2023, Kazia Therapeutics Ltd's EPS (Diluted) amounts to -0.1 AUD.
What is Kazia Therapeutics Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-6%
-6%
Over the last year, the EPS (Diluted) growth was 42%. The average annual EPS (Diluted) growth rates for Kazia Therapeutics Ltd have been 12% over the past three years , 2% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
